This study aimed to investigate the expression of immunoglobulins (IgG, IgM, IgA) and complement component 3 (C3) in the lungs of patients with DM-ILD and those with idiopathic pulmonary fibrosis (IPF) as control. Here, CD79A is linked to interstitial lung disease.